These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 8196506
41. Epibatidine is a nicotinic analgesic. Qian C, Li T, Shen TY, Libertine-Garahan L, Eckman J, Biftu T, Ip S. Eur J Pharmacol; 1993 Dec 21; 250(3):R13-4. PubMed ID: 8112391 [Abstract] [Full Text] [Related]
43. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, Sullivan JP. J Pharmacol Exp Ther; 1996 Jan 21; 276(1):289-97. PubMed ID: 8558445 [Abstract] [Full Text] [Related]
44. Genetic correlation between the free-choice oral consumption of nicotine and alcohol in C57BL/6JxC3H/HeJ F2 intercross mice. Li XC, Karadsheh MS, Jenkins PM, Stitzel JA. Behav Brain Res; 2005 Feb 10; 157(1):79-90. PubMed ID: 15617774 [Abstract] [Full Text] [Related]
45. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment. Meyers EE, Loetz EC, Marks MJ. Pharmacol Biochem Behav; 2015 Mar 10; 130():1-8. PubMed ID: 25560939 [Abstract] [Full Text] [Related]
46. Effects of chronic treatment with (+)-nicotine on the stress-induced hypertension and downregulation of central nicotinic receptors in rats: comparative study with (-)-nicotine. Takita M, Taniguchi T, Zhu J, Piao HL, Tsai TY, Muramatsu I. Gen Pharmacol; 1999 Jul 10; 33(1):29-33. PubMed ID: 10428013 [Abstract] [Full Text] [Related]
47. Interaction of p-aminophenyldichloroarsine, an arsenical with specificity for vicinal cysteines, with [3H]cytisine binding sites in rat brain membranes. Aplin A, Wonnacott S. Biochem Pharmacol; 1994 Aug 03; 48(3):473-7. PubMed ID: 8068034 [Abstract] [Full Text] [Related]
48. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity. Parker MJ, Beck A, Luetje CW. Mol Pharmacol; 1998 Dec 03; 54(6):1132-9. PubMed ID: 9855644 [Abstract] [Full Text] [Related]
49. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis. Bellanger C, Halm MP, Dauphin F, Chichery R. Neurosci Lett; 2005 Oct 28; 387(3):162-7. PubMed ID: 16026931 [Abstract] [Full Text] [Related]
50. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ. Br J Pharmacol; 2000 Oct 28; 131(4):729-39. PubMed ID: 11030722 [Abstract] [Full Text] [Related]
51. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP. J Pharmacol Exp Ther; 1998 May 28; 285(2):777-86. PubMed ID: 9580626 [Abstract] [Full Text] [Related]
52. Depressive characteristics of FSL rats: involvement of central nicotinic receptors. Tizabi Y, Rezvani1 AH, Russell LT, Tyler KY, Overstreet DH. Pharmacol Biochem Behav; 2000 May 28; 66(1):73-7. PubMed ID: 10837845 [Abstract] [Full Text] [Related]
54. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Bannon AW, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ. J Pharmacol Exp Ther; 1994 Nov 28; 271(2):624-31. PubMed ID: 7965777 [Abstract] [Full Text] [Related]
55. 2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors. Chefer SI, Horti AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, Mukhin AG, London ED. Neuroreport; 1999 Sep 09; 10(13):2715-21. PubMed ID: 10511429 [Abstract] [Full Text] [Related]
56. The role of beta 2-subunit-containing nicotinic acetylcholine receptors in the brain explored with a mutant mouse. Léna C, Changeux JP. Ann N Y Acad Sci; 1999 Apr 30; 868():611-6. PubMed ID: 10414341 [Abstract] [Full Text] [Related]
57. 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements. Ettrup A, Mikkelsen JD, Lehel S, Madsen J, Nielsen EØ, Palner M, Timmermann DB, Peters D, Knudsen GM. J Nucl Med; 2011 Sep 30; 52(9):1449-56. PubMed ID: 21828113 [Abstract] [Full Text] [Related]
58. Synthesis of analogues of (-)-cytisine for in vivo studies of nicotinic receptors using positron emission tomography. Marrière E, Rouden J, Tadino V, Lasne MC. Org Lett; 2000 Apr 20; 2(8):1121-4. PubMed ID: 10804569 [Abstract] [Full Text] [Related]
59. Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Ghedini PC, Avellar MC, De Lima TC, Lima-Landman MT, Lapa AJ, Souccar C. Brain Res; 2012 Nov 05; 1483():96-104. PubMed ID: 22995368 [Abstract] [Full Text] [Related]
60. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. Schwartz RD, Kellar KJ. J Neurochem; 1985 Aug 05; 45(2):427-33. PubMed ID: 4009168 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]